Clinicians' opinions on recommending aspirin to prevent colorectal cancer to Australians aged 50-70 years: a qualitative study
Shakira Milton, Jennifer McIntosh, Thivagar Yogaparan, Pavithran Alphonse, Sibel Saya, Napin Karnchanachari, Peter Nguyen, Phyllis Lau, Finlay Macrae, Jon Emery
BMJ Open | BMJ PUBLISHING GROUP | Published : 2021
OBJECTIVES: Australian guidelines recommend all adults aged 50-70 years old without existing contraindications consider taking low-dose aspirin (100-300 mg per day) for at least 2.5 years to reduce their risk of developing colorectal cancer. We aimed to explore clinicians' practices, knowledge, opinions, and barriers and facilitators to the implementation of these new guidelines. METHODS: Semistructured interviews were conducted with clinicians to whom the new guidelines may be applicable (Familial Cancer Clinic staff (geneticists, oncologists and genetic counsellors), gastroenterologists, pharmacists and general practitioners (GPs)). The Consolidated Framework for Implementation Research (C..View full abstract
Awarded by Victorian Comprehensive Cancer Centre Precision Prevention Program
This project was funded by a dedicated grant from the Victorian Comprehensive Cancer Centre Precision Prevention Program: VCCC 075739.